[28-53-pm1] Social Pharmacy 3, Regulatory sciences

[28-53-pm1-04] Current status of package insert revisions based on PMDA consultations — Toward enhanced utilization —

○Sachi Miyahara¹, Taisuke Ariyoshi², Tomoko Chikura³, Yoshiko Nakano⁴, Yasuyuki Hattori⁴ (1. Bayer Yakuhin, 2. Novartis Pharma , 3. Astellas Pharma , 4. Daiichi Sankyo)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.